PDCD1LG2 and head and neck squamous cell carcinoma: However, recent studies have demonstrated that PD-L2 is also highly expressed in various human cancers, including head and neck squamous cell carcinoma, lung squamous cell carcinoma, renal cell carcinoma, pancreatic ductal adenocarcinoma, and cervical cancer (11–14).